Hello, I am Janey Willis, ISN Guide to Diabetes. Type 1 Diabetes is an autoimmune disease, and Type 2 Diabetes is caused by risk factors such as lifestyle, ethnicity, age, and pregnancy. The majority of diabetics have Type 2. See Disclaimer.
|Clinical Trials for Diabetes||Research on Diabetes|
Clinical trials give patients the opportunity to try treatments that are still in development. Ask your diabetic specialist if there are any clinical trials suitable for you. (Also see Autoimmune Diseases and Overview of Diabetes)
Pancreas Cell Transplants Can Help People With Severe Diabetes: Study. Transplants of insulin–producing pancreas cells are a long hoped–for treatment for diabetes. Philly Voice, 04/19/2016.
Hope for Reversing Type 2 Diabetes. New research raises the tantalizing possibility that drastic changes in diet may reverse Type 2 diabetes in some people. New York Times, 04/18/2016.
Diabetes could be revolutionised by new skin patch that tests blood sugar AND delivers drugs when needed. A patch that measures sugar in a diabetic's sweat could spell an end to painful insulin injections and finger jab tests. Mail Online, 03/21/2016.
Artificial pancreas provides better real-world control of type 1 diabetes. A system that combines frequent blood sugar measurements with software that varies the rate at which insulin is pumped into the body can significantly improve glucose control in type 1 diabetics. Reuters, 09/17/2015.
Prediabetes Increases Cancer Risk By 15%. A new study published in Diabetologia shows a link between prediabetes and cancer, especially in the liver, stomach, pancreas, breast, and endometrium. Time Healthland, 09/06/2014. (Also see Cancer)
Hyperbaric Oxygen Improves Diabetic Ulcers Regardless of Glycemia. Hyperbaric oxygen is increasingly used as an adjunct to antibiotics, debridement, and revascularization for therapy of chronic nonhealing wounds associated with diabetes mellitus. Clinical Endocrinology News, 2012.
Anti-Inflammatory Therapy in Type 1 Diabetes. Here, we review recent advances in anti-inflammatory interventions in Type 1 Diabetes (T1D) animal models and preclinical studies and discuss their mode of action as well as their capacity to interfere with T1D development. PubMed, Curr Diab Rep, 2012 Jul 13.
Polyglandular autoimmunity in autoimmune thyroid disease (AITD) behaves differently from polyglandular autoimmunity in type 1 diabetes. AITD shows clustering of gastric autoimmunity with celiac and adrenal autoimmunity, which is consistent with the proposed entity of the autoimmune polyglandular syndrome type 2. J. Wiebolt. Endocrine Abstracts, . (Also see Thyroid Disease)
Reading Voices of Scleroderma Books: Diana Kramer.
Sharing Scleroderma Awareness Bracelets: Deb Martin, Brenda Miller, Vickie Risner.
Thanks to UNITED WAY donors of Central New Mexico and Snohomish County!
Patricia Ann Black: Marilyn Currier, Shelley Ensz, Richard Howitt, Gerald and Pat Ivanejko, Juno Beach Condo Association, Keith and Rosalyn Miller, and Elaine Wible.
Gayle Hedlin: Daniel and Joann Pepper and Nancy Smithberg.
Janet Paulmenn: Anonymous, Mary Jo Austin, Shelley Blaser, Susan Book, Dennis and Pat Clayton, Grace Cunha, Cindy Dorio, Michael and Patricia Donahue, Shelley Ensz, Nancy Falkenhagen, Jo Frowde, Alice Gigl, Margaret Hollywood, Karen Khalaf and Family, Susan Kvarantan, Bradley Lawrence, Jillyan Little, Donna Madge, Michele Maxson, Barry and Judith McCabe, John Moffett, My Tribute Foundation, Joan-Marie Permison, John Roberts, Margaret Roof, Maryellen Ryan, Mayalin and Kiralee Murphy, Nancy Settle-Murphy, and Bruce and Elizabeth Winter.
SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to:
International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email [email protected] to request our Welcome email, or to report bad links or to update this page content.